Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine, Senegal
- PMID: 22706959
- DOI: 10.1007/s00436-012-2994-7
Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine, Senegal
Abstract
The goal of the present study was to assess the evolution of the in vitro chloroquine resistance and also the prevalence of pfcrt T76 and pfmdr1 Y86 mutations in Pikine from 2000 while chloroquine (CQ) was the first-line treatment of malaria to 2009 when artemisinin-based combination therapies (ACTs) are in use. We genotyped pfcrt K76T and pfmdr1 N86Y polymorphisms by PCR-RFLP and assessed in vitro CQ susceptibility by double-site enzyme-linked pLDH immunodetection (DELI) assay in Plasmodium falciparum isolates collected in Pikine, Senegal. The proportions of the pfcrt T76 allele in the light of the three different treatment policies were 72.4 % before CQ withdrawal (2000 to 2003), 47.2% while amodiaquine plus Fansidar was the first-line treatment (2004 to 2005), and 59.5 % since the ACT use was implemented (2006 to 2009). The prevalence of pfcrt T76 decreased significantly after CQ was stopped [X (2) = 6.54, P = 0.01 (2000-2003 versus 2004-2005)] and then slightly since ACTs have been implemented [X(2) = 1.12, P = 0.28 (2000-2003 versus 2006-2009)]. There were no significant differences on the prevalence of pfmdr1 Y86 throughout the three treatment policies. The DELI assay was carried out episodically in 2000 (n = 36), 2001 (n = 47), and 2009 (n = 37). The mean IC(50)s of the isolates to CQ in 2000 versus 2009 and 2001 versus 2009 are significantly different (P < 0.05). The Fisher exact test found a significant association between the presence of the pfcrt T76 mutant allele and in vitro resistance in 2000/2001 (P = 0.023), while in 2009 there were no association between both variables (P = 0.274). Mutant pfcrt T76 and pfmdr1 Y86 alleles and in vitro CQ-resistant strains are still circulating in Pikine. The official discontinuation of CQ use is not completely followed by its total withdrawal from private drug sellers, and the molecule still exerts pressure on local P. falciparum populations.
Similar articles
-
The detection of pfcrt and pfmdr1 point mutations as molecular markers of chloroquine drug resistance, Pahang, Malaysia.Malar J. 2012 Aug 1;11:251. doi: 10.1186/1475-2875-11-251. Malar J. 2012. PMID: 22853645 Free PMC article.
-
Synergism between Pfcrt and Pfmdr1 genes could account for the slow recovery of chloroquine sensitive Plasmodium falciparum strains in Ghana after chloroquine withdrawal.J Infect Public Health. 2017 Jan-Feb;10(1):110-119. doi: 10.1016/j.jiph.2016.02.004. Epub 2016 Mar 26. J Infect Public Health. 2017. PMID: 27026134
-
In vitro chloroquine susceptibility and PCR analysis of pfcrt and pfmdr1 polymorphisms in Plasmodium falciparum isolates from Senegal.Am J Trop Med Hyg. 2002 May;66(5):474-80. doi: 10.4269/ajtmh.2002.66.474. Am J Trop Med Hyg. 2002. PMID: 12201579
-
Molecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studies.Malar J. 2012 Sep 19;11:333. doi: 10.1186/1475-2875-11-333. Malar J. 2012. PMID: 22992214 Free PMC article.
-
Molecular surveillance of chloroquine-resistant Plasmodium falciparum in sub-Saharan African countries after withdrawal of chloroquine for treatment of uncomplicated malaria: A systematic review.J Infect Public Health. 2022 May;15(5):550-557. doi: 10.1016/j.jiph.2022.03.015. Epub 2022 Mar 29. J Infect Public Health. 2022. PMID: 35447389
Cited by
-
Plasmodium falciparum In Vitro Resistance to Monodesethylamodiaquine, Dakar, Senegal, 2014.Emerg Infect Dis. 2016 May;22(5):841-5. doi: 10.3201/eid2205.151321. Emerg Infect Dis. 2016. PMID: 27088703 Free PMC article.
-
Ex vivo susceptibility and genotyping of Plasmodium falciparum isolates from Pikine, Senegal.Malar J. 2017 Jun 14;16(1):250. doi: 10.1186/s12936-017-1897-6. Malar J. 2017. PMID: 28615016 Free PMC article.
-
Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.Malar J. 2013 Mar 20;12:107. doi: 10.1186/1475-2875-12-107. Malar J. 2013. PMID: 23510258 Free PMC article.
-
PfCRT and its role in antimalarial drug resistance.Trends Parasitol. 2012 Nov;28(11):504-14. doi: 10.1016/j.pt.2012.08.002. Epub 2012 Sep 25. Trends Parasitol. 2012. PMID: 23020971 Free PMC article. Review.
-
Confirmation of Plasmodium falciparum in vitro resistance to monodesethylamodiaquine and chloroquine in Dakar, Senegal, in 2015.Malar J. 2017 Mar 16;16(1):118. doi: 10.1186/s12936-017-1773-4. Malar J. 2017. PMID: 28302108 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources